Related Experiment Video
Updated: Jan 31, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Development and validation of a new glaucoma screening test using temporally modulated flicker
Bruno R Fidalgo1, Anish Jindal1, Christopher W Tyler1
1Centre for Applied Vision Research, School of Health Sciences, City, University of London, London, UK.
The Accelerator 4-Alternative Forced-Choice Flicker Test prototype (A4FTp) shows comparable accuracy to existing methods for detecting chronic open angle glaucoma (COAG). This rapid test offers promising results for future glaucoma screening.
Area of Science:
- Ophthalmology
- Medical Diagnostics
- Visual Science
Background:
- Chronic open angle glaucoma (COAG) is a progressive optic neuropathy.
- Early detection is crucial for preventing irreversible vision loss.
- Current diagnostic tools have limitations in speed or accessibility.
Purpose of the Study:
- To evaluate the psychometric properties and diagnostic accuracy of the Accelerator 4-Alternative Forced-Choice Flicker Test prototype (A4FTp).
- To assess the A4FTp's potential for detecting chronic open angle glaucoma (COAG).
Main Methods:
- The A4FTp measures flicker thresholds in vulnerable visual field regions.
- Psychometric properties were assessed in 20 normal subjects.
- Diagnostic accuracy was compared against Frequency Doubling Technology (FDT) and Spectral Domain Optical Coherence Tomography (SD-OCT) in 40 COAG patients and 38 controls.
- Area Under the Receiver Operator Characteristic Curve (AUROC) was used for accuracy analysis.
Main Results:
- A4FTp demonstrated stable flicker thresholds with good test-retest repeatability.
- The A4FTp achieved an AUROC of 0.82, comparable to SD-OCT (0.90) and FDT (0.91).
- The A4FTp test duration averaged just over 2 minutes per eye, significantly faster than standard visual field testing.
Conclusions:
- The A4FTp exhibits diagnostic accuracy comparable to established methods for COAG detection.
- The test's short duration and promising initial results suggest potential for glaucoma screening.
- Further refinement of the A4FTp could establish its role in clinical practice.
Related Concept Videos
Reliability and Validity
In Vitro Drug Release Testing: Overview, Development and Validation
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Data Validation
Key parameters for method validation include:

